ANXA1 and cancer: On the one hand loosing ANXA1 would be beneficial for cancer cells because it could lead to resistance to apoptosis but on the other hand the presence of ANXA1 during apoptosis creates peripheral immune tolerance of cancer antigens by Dectin-1 receptor which helps the cancer being unnoticed by the immune system.